LBC
LLY icon

Leigh Baldwin & Co’s Eli Lilly LLY Stock Holding History

Leigh Baldwin & Co’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.35M Buy
1,467
+33
+2% +$33.5K 0.87% 31
2025
Q4 		$1.54M Sell
1,434
-52
-3% -$49.7K 1.01% 23
2025
Q3 		$1.13M Buy
1,486
+407
+38% +$303K 0.64% 36
2025
Q2 		$841K Buy
1,079
+10
+0.9% +$7.77K 0.55% 47
2025
Q1 		$883K Hold
1,069
– – 0.71% 38
2024
Q4 		$825K Buy
+1,069
New +$885K 0.7% 40

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Leigh Baldwin & Co's LLY Position: Q1 2026 in Review

Leigh Baldwin & Co increased its Eli Lilly (LLY) stake by 2.3% in Q1 2026, buying an estimated $33.5K and bringing the position to 1,467 shares worth $1.35M. The position accounts for 0.87% of the portfolio, ranked #31.

Leigh Baldwin & Co first reported a position in LLY in Q4 2024 and has held it in 6 quarters since. The position peaked at $1.54M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Leigh Baldwin & Co held 1,467 shares of Eli Lilly worth $1.35M as of Q1 2026.
  • Leigh Baldwin & Co bought 33 Eli Lilly shares in Q1 2026, an estimated $33.5K.
  • Eli Lilly made up 0.87% of Leigh Baldwin & Co's portfolio in Q1 2026, its #31 holding.
  • Leigh Baldwin & Co first reported a position in Eli Lilly in Q4 2024 and has held it in 6 quarters since.
  • Leigh Baldwin & Co's Eli Lilly position peaked at $1.54M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Leigh Baldwin & Co's 13F filing for Q1 2026, filed 20 May 2026.